Alfredo Morabia
Alfredo Morabia has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Michael C. Costanza
Division of Clinical Epidemiology, Geneva University Hospitals, Geneva, Switzerland
2 shared publications- Alan D. Lopez
Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
1 shared publication Anne Hardy
1 shared publicationBarbara M. Ross
Columbia Genome Center
1 shared publication- Christine Bouchardy
Geneva Cancer Registry, Institute for Social and Preventive Medicine, University of Geneva, Switzerland
1 shared publication Eftihia Cayanis
Columbia Genome Center
1 shared publication
Latest Publications
- Open Access
- 12 May 2006
- Published by Springer Nature in BMC Public Health
- Vol. 6 (1) , 130
Gender differentials in the evolution of cigarette smoking habits in a general European adult population from 1993–2003
Background: Describe the recent evolution of cigarette smoking habits by gender in Geneva, where incidence rates of lung cancer have been declining in men but increasing in women. Methods: Continuous cross-sectional surveillance of the general adult (35–74 yrs) population of Geneva, Switzerland for 11 years (1993–2003) using a locally-validated smoking questionnaire, yielding a representative random sample of 12,271 individuals (6,164 men, 6,107 women). Results: In both genders, prevalence of current cigarette smoking was stable over the 11-year period, at about one third of men and one quarter of women, even though smoking began at an earlier age in more recent years. Older men were more likely to be former smokers than older women. Younger men, but not women, tended to quit smoking at an earlier age. Conclusion: This continuous (1993–2003) risk factor surveillance system, unique in Europe, shows stable prevalence of smoking in both genders. However, sharp contrasts in age-specific prevalence of never and former smoking and of ages at smoking initiation indicate that smoking continues a long-term decline in men but has still not reached its peak in women.
- 12 May 2006
- Published by Springer Nature in BMC Public Health
- Vol. 6 (1) , 130
Open AccessGender differentials in the evolution of cigarette smoking habits in a general European adult population from 1993–2003
Background: Describe the recent evolution of cigarette smoking habits by gender in Geneva, where incidence rates of lung cancer have been declining in men but increasing in women. Methods: Continuous cross-sectional surveillance of the general adult (35–74 yrs) population of Geneva, Switzerland for 11 years (1993–2003) using a locally-validated smoking questionnaire, yielding a representative random sample of 12,271 individuals (6,164 men, 6,107 women). Results: In both genders, prevalence of current cigarette smoking was stable over the 11-year period, at about one third of men and one quarter of women, even though smoking began at an earlier age in more recent years. Older men were more likely to be former smokers than older women. Younger men, but not women, tended to quit smoking at an earlier age. Conclusion: This continuous (1993–2003) risk factor surveillance system, unique in Europe, shows stable prevalence of smoking in both genders. However, sharp contrasts in age-specific prevalence of never and former smoking and of ages at smoking initiation indicate that smoking continues a long-term decline in men but has still not reached its peak in women.
- 1 April 2006
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 21 (4) , 333-335
Thomas M. Daniel. Wade Hampton Frost. Pioneer Epidemiologist 1880–1938. Up to the Mountain
- 1 April 2006
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 21 (4) , 333-335
Thomas M. Daniel. Wade Hampton Frost. Pioneer Epidemiologist 1880–1938. Up to the Mountain
- Open Access
- 22 March 2006
- Published by Springer Nature in BMC Cancer
- Vol. 6 (1) , 78
Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy
Background: This article aims to explain the reasons for the remarkable change in age of breast cancer occurrence in the Swiss canton of Geneva. Methods: We used population-based data from the Geneva cancer registry, which collects information on method of detection, stage and tumour characteristics since 1975. For patients diagnosed between 1997–2003, we obtained additional information on use of hormone replacement therapy from a large prospective study on breast cancer. Using generalized log linear regression analysis, we compared age-specific incidence rates with respect to period, stage, oestrogen receptor status, method of detection and use of hormone replacement therapy. Results: In the periods 1975–1979 and 1985–1989, breast cancer risk increased with age, showing the highest incidence rates among women aged ≥ 85 years. From 1997, the age-specific incidence curve changed completely (p < 0.0001), showing an incidence peak at 60–64 years and a reduced incidence among elderly women. This incidence peak concerned mainly early stage and oestrogen positive cancers and was exclusively observed among women who ever used hormone replacement therapy, regardless whether the tumour was screen-detected or not. Conclusion: The increasing prevalence of hormone replacement therapy use during the 1990s could explain the important change in age-specific breast cancer incidence, not only by increasing breast cancer risk, but also by revealing breast cancer at an earlier age.
- 22 March 2006
- Published by Springer Nature in BMC Cancer
- Vol. 6 (1) , 78
Open AccessRemarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy
Background: This article aims to explain the reasons for the remarkable change in age of breast cancer occurrence in the Swiss canton of Geneva. Methods: We used population-based data from the Geneva cancer registry, which collects information on method of detection, stage and tumour characteristics since 1975. For patients diagnosed between 1997–2003, we obtained additional information on use of hormone replacement therapy from a large prospective study on breast cancer. Using generalized log linear regression analysis, we compared age-specific incidence rates with respect to period, stage, oestrogen receptor status, method of detection and use of hormone replacement therapy. Results: In the periods 1975–1979 and 1985–1989, breast cancer risk increased with age, showing the highest incidence rates among women aged ≥ 85 years. From 1997, the age-specific incidence curve changed completely (p < 0.0001), showing an incidence peak at 60–64 years and a reduced incidence among elderly women. This incidence peak concerned mainly early stage and oestrogen positive cancers and was exclusively observed among women who ever used hormone replacement therapy, regardless whether the tumour was screen-detected or not. Conclusion: The increasing prevalence of hormone replacement therapy use during the 1990s could explain the important change in age-specific breast cancer incidence, not only by increasing breast cancer risk, but also by revealing breast cancer at an earlier age.
- Open Access
- 1 March 2006
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 99 (3) , 158-160
Pierre-Charles-Alexandre Louis and the evaluation of bloodletting
- 1 March 2006
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 99 (3) , 158-160
Open AccessPierre-Charles-Alexandre Louis and the evaluation of bloodletting
- Open Access
- 1 March 2006
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 99 (3) , 158-160
Pierre-Charles-Alexandre Louis and the Evaluation of Bloodletting
Additional material for this article is available from The James Lind Library website [ www.jameslindlibrary.org ] where this paper was previously published.
- 1 March 2006
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 99 (3) , 158-160
Open AccessPierre-Charles-Alexandre Louis and the Evaluation of Bloodletting
Additional material for this article is available from The James Lind Library website [ www.jameslindlibrary.org ] where this paper was previously published.
- 1 January 2006
- Published by Wolters Kluwer Health in Menopause
- Vol. 13 (1) , 111-115
Recent reversal of trends in hormone therapy use in a European population
The impact of the Women's Health Initiative (WHI) randomized trial results published in July 2002 indicating that hormone therapy (HT) is potentially harmful for the heart and the mammary gland of naturally postmenopausal women was assessed for the first time in a European population. This study continuously monitored HT use from 1994 through 2003 in a population-based random sample of 5,758 women aged 35 to 74 years residing in Geneva (city and canton), Switzerland, yielding 1,938 naturally postmenopausal women with an intact uterus and 206 artificially postmenopausal women. Women in the former subgroup weighed substantially less than their WHI trial counterparts but were not otherwise at lower risk for cardiovascular disease. Among the naturally postmenopausal women with an intact uterus, current HT use increased from 29% to 46% (P < 0.0001) through July 2002 and then decreased abruptly to 31% in 2003. Current HT use remained stable (range, 38%-46%; trend P = 0.92) among the artificially postmenopausal women. Successive annual increases from 1994 through 2001 in the prevalence of current HT use by postmenopausal women living in Geneva were dramatically reversed to the level in 1994 just after the results of the WHI trial were published, but only for naturally postmenopausal women with an intact uterus. Approximately one in three of the latter women who stopped using HT may also have lost its beneficial effects on bone health.
- 1 January 2006
- Published by Wolters Kluwer Health in Menopause
- Vol. 13 (1) , 111-115
Recent reversal of trends in hormone therapy use in a European population
The impact of the Women's Health Initiative (WHI) randomized trial results published in July 2002 indicating that hormone therapy (HT) is potentially harmful for the heart and the mammary gland of naturally postmenopausal women was assessed for the first time in a European population. This study continuously monitored HT use from 1994 through 2003 in a population-based random sample of 5,758 women aged 35 to 74 years residing in Geneva (city and canton), Switzerland, yielding 1,938 naturally postmenopausal women with an intact uterus and 206 artificially postmenopausal women. Women in the former subgroup weighed substantially less than their WHI trial counterparts but were not otherwise at lower risk for cardiovascular disease. Among the naturally postmenopausal women with an intact uterus, current HT use increased from 29% to 46% (P < 0.0001) through July 2002 and then decreased abruptly to 31% in 2003. Current HT use remained stable (range, 38%-46%; trend P = 0.92) among the artificially postmenopausal women. Successive annual increases from 1994 through 2001 in the prevalence of current HT use by postmenopausal women living in Geneva were dramatically reversed to the level in 1994 just after the results of the WHI trial were published, but only for naturally postmenopausal women with an intact uterus. Approximately one in three of the latter women who stopped using HT may also have lost its beneficial effects on bone health.
- 1 January 2006
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 17 (1) , 115-119
???East Side Story???: On Being an Epidemiologist in the Former USSR
Marcus Klingberg was born on 7 October 1918, in Warsaw, Poland, into a Hasidic, rabbinical family. After the Nazi invasion of Poland, he escaped to the USSR where he trained and worked as an epidemiologist from 1939 to 1945. For 35 years after the war, he continued his professional work in Israel. The harsh conditions within the Soviet Union during World War II provided a challenging setting for epidemiologic work—a setting that has remained largely hidden from Western view. In this interview, Klingberg describes his work as an epidemiologist in the USSR and his subsequent encounter with Western epidemiology.
- 1 January 2006
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 17 (1) , 115-119
???East Side Story???: On Being an Epidemiologist in the Former USSR
Marcus Klingberg was born on 7 October 1918, in Warsaw, Poland, into a Hasidic, rabbinical family. After the Nazi invasion of Poland, he escaped to the USSR where he trained and worked as an epidemiologist from 1939 to 1945. For 35 years after the war, he continued his professional work in Israel. The harsh conditions within the Soviet Union during World War II provided a challenging setting for epidemiologic work—a setting that has remained largely hidden from Western view. In this interview, Klingberg describes his work as an epidemiologist in the USSR and his subsequent encounter with Western epidemiology.
- 1 October 2005
- Published by Springer Nature in International Journal of Public Health
- Vol. 50 (5) , 277-278
SPM, 50 years: mostly red
- 1 October 2005
- Published by Springer Nature in International Journal of Public Health
- Vol. 50 (5) , 277-278
SPM, 50 years: mostly red
- Open Access
- 15 April 2005
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 161 (8) , 714-724
Relative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population
The authors evaluated the contributions of nine genetic (G) variants (selected from 275 single nucleotide polymorphisms in 11 reverse cholesterol transport pathway genes), five environmental (E) factors (selected from 10), and G × G, E × E, and G × E interactions in explaining population variance of blood lipid concentrations. Total cholesterol, triglycerides, and high density lipoprotein (HDL) cholesterol were measured, and low density lipoprotein (LDL) cholesterol and HDL cholesterol/LDL cholesterol ratio were calculated in a population-based random sample of 1,543 men and women in Geneva, Switzerland, aged 35–74 years in 1999–2001. Explained variances (R2) for HDL cholesterol/LDL cholesterol ratio, HDL cholesterol, and LDL cholesterol, respectively, were 34%, 33%, and 19%, decomposed into main effects of G (6%, 4%, and 5%) and E (25%, 28%, and 11%), with just 3%, 2%, and 3% due to G × G, E × E, and G × E interactions, respectively. Risk factor clustering was only moderate: 70% of study subjects had ≤3 variants, 75% had ≤2 environmental exposures, and 69% had ≤5 of both types of factors. Multiple genes with weak associations, together with more dominating environmental factors, are involved in determining blood lipid concentrations. Interactions added little explained variance. Increasing trends in hypercholesterolemia are attributable to environmental changes affecting populations as a whole. Reducing obesity and smoking and moderating alcohol intake in entire populations should remain the primary strategies for lipid control.
- 15 April 2005
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 161 (8) , 714-724
Open AccessRelative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population
The authors evaluated the contributions of nine genetic (G) variants (selected from 275 single nucleotide polymorphisms in 11 reverse cholesterol transport pathway genes), five environmental (E) factors (selected from 10), and G × G, E × E, and G × E interactions in explaining population variance of blood lipid concentrations. Total cholesterol, triglycerides, and high density lipoprotein (HDL) cholesterol were measured, and low density lipoprotein (LDL) cholesterol and HDL cholesterol/LDL cholesterol ratio were calculated in a population-based random sample of 1,543 men and women in Geneva, Switzerland, aged 35–74 years in 1999–2001. Explained variances (R2) for HDL cholesterol/LDL cholesterol ratio, HDL cholesterol, and LDL cholesterol, respectively, were 34%, 33%, and 19%, decomposed into main effects of G (6%, 4%, and 5%) and E (25%, 28%, and 11%), with just 3%, 2%, and 3% due to G × G, E × E, and G × E interactions, respectively. Risk factor clustering was only moderate: 70% of study subjects had ≤3 variants, 75% had ≤2 environmental exposures, and 69% had ≤5 of both types of factors. Multiple genes with weak associations, together with more dominating environmental factors, are involved in determining blood lipid concentrations. Interactions added little explained variance. Increasing trends in hypercholesterolemia are attributable to environmental changes affecting populations as a whole. Reducing obesity and smoking and moderating alcohol intake in entire populations should remain the primary strategies for lipid control.
- 1 April 2005
- Published by American Public Health Association in American Journal of Public Health
- Vol. 95 (4) , 632-635
The Obesity Epidemic as Harbinger of a Metabolic Disorder Epidemic: Trends in Overweight, Hypercholesterolemia, and Diabetes Treatment in Geneva, Switzerland, 1993–2003
Increases in obesity, hypercholesterolemia, and diabetes may be under way in Europe. We have reported the only data available from the 1990s for continuous monitoring of chronic disease risk factors in random samples of a general European population. In random surveys (1993–2003) of 6164 men and 6107 women in Geneva, overweight and obesity combined increased in both men and women; hypercholesterolemia prevalence also rose; diabetes treatment increased in men. Only population-based interventions can prevent the impending epidemic of obesity-related disorders.
- 1 April 2005
- Published by American Public Health Association in American Journal of Public Health
- Vol. 95 (4) , 632-635
The Obesity Epidemic as Harbinger of a Metabolic Disorder Epidemic: Trends in Overweight, Hypercholesterolemia, and Diabetes Treatment in Geneva, Switzerland, 1993–2003
Increases in obesity, hypercholesterolemia, and diabetes may be under way in Europe. We have reported the only data available from the 1990s for continuous monitoring of chronic disease risk factors in random samples of a general European population. In random surveys (1993–2003) of 6164 men and 6107 women in Geneva, overweight and obesity combined increased in both men and women; hypercholesterolemia prevalence also rose; diabetes treatment increased in men. Only population-based interventions can prevent the impending epidemic of obesity-related disorders.